FIGURE
Figure 4
- ID
- ZDB-FIG-230401-31
- Publication
- Dong et al., 2023 - Augmentation of Pectoral Fin Teratogenicity by Thalidomide in Human Cytochrome P450 3A-Expressing Zebrafish
- Other Figures
- All Figure Page
- Back to All Figure Page
Figure 4
Effects of thalidomide on hCYP1A1-expressing zebrafish during development. Embryos/larvae of wild-type (WT) zebrafish and hCYP1A1-expressing zebrafish (hCYP1A1-zebrafish) were exposed to 200 μM thalidomide (TD) or 0.02% DMSO as a vehicle from 17 hpf to 72 hpf. (A,B, E,F): wild-type zebrafish. (C,D,G,H): hCYP1A1-zebrafish. Zebrafish in (A,E,C,G) were exposed to DMSO. Zebrafish in (B,F,D,H) were exposed to thalidomide. (A–D): dorsal views; (E–H): lateral views. Scale bars = 200 µm. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Pharmaceuticals (Basel)